Back
NAGE Niagen Bioscience Inc
Platform & Compounding FCF
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 25%
D- 30
  • 5yr Avg ROIC -7.1%
  • Operating Margin Trend +13.60 pp/yr

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -5.9%
  • 5yr Share-Count CAGR 6.2%

Growth Quality

Weight: 25%
A+ 98
  • 5yr Revenue CAGR 17.7%
  • 5yr EPS CAGR 81.8%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 20%
C- 44
  • 5yr FCF Margin -5.5%
  • 5yr FCF/NI Conversion 1.08x

Balance Sheet

Weight: 10%
A+ 100
  • Net Debt / EBITDA -3.94x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 5.87

Stability

Weight: 5%
A- 87
  • EPS Volatility (σ/μ) 0.00
  • Piotroski F-Score 5
  • Negative-Revenue Years (5) 0/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Not Followed

Not held by any curated guru.